Mercer Global Advisors’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$361K Sell
10,033
-125
-1% -$4.2K ﹤0.01% 2612
2026
Q1
$365K Buy
10,158
+143
+1% +$3.7K ﹤0.01% 2251
2025
Q4
$199K Sell
10,015
-15
-0.1% -$289 ﹤0.01% 2567
2025
Q3
$183K Buy
10,030
+30
+0.3% +$494 ﹤0.01% 2414
2025
Q2
$158K Hold
10,000
﹤0.01% 2112
2025
Q1
$127K Sell
10,000
-600
-6% -$9.42K ﹤0.01% 2030
2024
Q4
$233K Buy
+10,600
New +$223K ﹤0.01% 1886
2019
Q2
Sell
-21,266
Closed -$76K 1159
2019
Q1
$76K Buy
+21,266
New +$70.7K ﹤0.01% 1032

Other funds holding CLMT

Mercer Global Advisors's CLMT Position: Q2 2026 in Review

Mercer Global Advisors reduced its Calumet Specialty Products (CLMT) stake by 1.2% in Q2 2026, selling an estimated $4.2K and leaving 10,033 shares worth $361K. The position accounts for ﹤0.01% of the portfolio, ranked #2612.

Mercer Global Advisors first reported a position in CLMT in Q1 2019 and has held it in 8 quarters since. The position peaked at $365K in Q1 2026. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Mercer Global Advisors held 10,033 shares of Calumet Specialty Products worth $361K as of Q2 2026.
  • Mercer Global Advisors sold 125 Calumet Specialty Products shares in Q2 2026, an estimated $4.2K.
  • Calumet Specialty Products made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #2612 holding.
  • Mercer Global Advisors first reported a position in Calumet Specialty Products in Q1 2019 and has held it in 8 quarters since.
  • Mercer Global Advisors's Calumet Specialty Products position peaked at $365K in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.